ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

TechFinancial Timesabout 2 hours ago

Ascletis ASC37 Shows Superior Weight Loss in Mice

1 min read

Ascletis announced ASC37, a once-monthly subcutaneous GLP-1R/GIPR/GCGR triple peptide agonist. In a diet-induced obese mouse model, ASC37 demonstrated superior weight loss compared to other treatments.

Level

Hype check

Tap to vote and see what everyone thinks.

#ascletis #asc37 #glp-1

Read full story

More to chew on!

Chips5 days ago

Science Corporation's vision-restoring chip wins EU approval

Health6 days ago

Novo sues Eli Lilly over weight-loss drug ads

Health7 days ago

FDA peptide vote could create $30B telehealth market

Summary by ByteBrief